<?xml version="1.0" encoding="UTF-8"?>
<p id="Par19">Regarding the prevalence of viral hepatitis, 3.2% of patients tested anti-HCV positive, a value 3 times higher than the 0.99% recently reported from the same area
 <sup>
  <xref ref-type="bibr" rid="CR26">26</xref>
 </sup>. Only 2 of the anti-HCV-positive patients had a detectable viral load. These findings can be explained by the fact that several anti-HCV-positive liver transplant recipients with PTLD had already achieved sustained virological response. As was expected, the prevalence of HBsAg and anti-HBc was similar to previously reported values
 <sup>
  <xref ref-type="bibr" rid="CR26">26</xref>,
  <xref ref-type="bibr" rid="CR27">27</xref>
 </sup>.
</p>
